ACHC

Acadia Healthcare Company, Inc.

55
Fundamentals39/ 100
Valuation50/ 100
Upside potential62/ 100
Risk potential38/ 100

ACHC lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.

ACHC Fundamentals

MetricStatus
Stable
Weak
Under pressure
Weak

ACHC's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.

ACHC PE Valuation

ACHC has no meaningful PE right now: it lost money over the past year.

ACHC Forward outlook

MetricOutlook
--
Strong growth
Growth
Strongly improving
Limited
Low

Analysts expect earnings and revenue growth for ACHC, with profitability improving. However, they disagree widely on these estimates.

ACHC Risk to reward

ScenarioChangePrice
Upside+62%$61.42
Downside-38%$23.61

Calculated from the latest close: $37.81 on Nov 12.

ACHC's one-year upside scenario is somewhat larger than its downside: +62% against −38%.

ACHC Earnings Per Share

Q4 2023: $-0.24Q1 2024: $-0.13Q2 2024: $-0.07Q3 2024: $3.06Q4 2024: $2.78Q1 2025: $2.04Q2 2025: $1.52Q3 2025: $1.18Q4 2025: $-12.16Q1 2026: $-12.20Q2 2026: $-12.41Q3 2026: $-12.43Forward: $2.02
Q4 2023: $-0.24Q1 2024: $-0.13Q2 2024: $-0.07Q3 2024: $3.06Q4 2024: $2.78Q1 2025: $2.04Q2 2025: $1.52Q3 2025: $1.18Q4 2025: $-12.16Q1 2026: $-12.20Q2 2026: $-12.41Q3 2026: $-12.43Forward: $2.02
QuarterTTM EPSYoY
Forward$2.02—
Q3 2026-$12.43-1153%
Q2 2026-$12.41-916%
Q1 2026-$12.20-698%
Q4 2025-$12.16-537%
Q3 2025$1.18-61%
Q2 2025$1.52+$1.59
Q1 2025$2.04+$2.17
Q4 2024$2.78+$3.02

ACHC has swung to a loss: it lost $12.43 per share over the past year, after a profit the year before.

ACHC Quarterly Revenue

Q4 2023: $743MQ1 2024: $768MQ2 2024: $796MQ3 2024: $816MQ4 2024: $774MQ1 2025: $771MQ2 2025: $869MQ3 2025: $852MQ4 2025: $821MQ1 2026: $829MQ2 2026: $866MQ3 2026: $895M
Q4 2023: $743MQ1 2024: $768MQ2 2024: $796MQ3 2024: $816MQ4 2024: $774MQ1 2025: $771MQ2 2025: $869MQ3 2025: $852MQ4 2025: $821MQ1 2026: $829MQ2 2026: $866MQ3 2026: $895M
QuarterRevenueYoY
Q3 2026$895.3M+5.1%
Q2 2026$865.8M-0.4%
Q1 2026$828.8M+7.6%
Q4 2025$821.5M+6.1%
Q3 2025$851.6M+4.4%
Q2 2025$869.2M+9.2%
Q1 2025$770.5M+0.3%
Q4 2024$774.2M+4.2%

ACHC's revenue is growing: $895M last quarter, up 5.1% from the same quarter a year ago.

ACHC Free Cash Flow

Q4 2023: −$22MQ1 2024: −$464MQ2 2024: $17MQ3 2024: −$27MQ4 2024: −$87MQ1 2025: −$163MQ2 2025: −$34MQ3 2025: −$63MQ4 2025: −$179MQ1 2026: −$15MQ2 2026: $124MQ3 2026: $47M
Q4 2023: −$22MQ1 2024: −$464MQ2 2024: $17MQ3 2024: −$27MQ4 2024: −$87MQ1 2025: −$163MQ2 2025: −$34MQ3 2025: −$63MQ4 2025: −$179MQ1 2026: −$15MQ2 2026: $124MQ3 2026: $47M
QuarterFree cash flowYoY
Q3 2026$47.1M+$110.2M
Q2 2026$123.5M+$157.8M
Q1 2026-$15M+$148.1M
Q4 2025-$179.5M-$92.7M
Q3 2025-$63M-$35.9M
Q2 2025-$34.2M-303%
Q1 2025-$163.2M+$300.5M
Q4 2024-$86.8M-$64.4M

ACHC has burned cash in six of the last eight quarters: −$24M over the past year, against −$347M the year before.

ACHC Total Shares

Q4 2023: 91MQ1 2024: 92MQ2 2024: 92MQ3 2024: 92MQ4 2024: 92MQ1 2025: 92MQ2 2025: 90MQ3 2025: 91MQ4 2025: 91MQ1 2026: 91MQ2 2026: 91MQ3 2026: 92M
Q4 2023: 91MQ1 2024: 92MQ2 2024: 92MQ3 2024: 92MQ4 2024: 92MQ1 2025: 92MQ2 2025: 90MQ3 2025: 91MQ4 2025: 91MQ1 2026: 91MQ2 2026: 91MQ3 2026: 92M
PeriodChange %Net change
Quarterly+0.4%+372K shares
1 year+1.3%+1.2M shares
3 years+0.6%+578K shares
5 years+0.9%+857K shares
Available history+4.5%+3.9M shares

ACHC has 92M diluted shares, up 1.3% from a year ago.

ACHC Net Leverage

Q4 2023: 11.9xQ1 2024: 14.2xQ2 2024: 12.7xQ3 2024: 3.4xQ4 2024: 3.8xQ1 2025: 5.1xQ2 2025: 5.7xQ3 2025: 6.8x
Q4 2023: 11.9xQ1 2024: 14.2xQ2 2024: 12.7xQ3 2024: 3.4xQ4 2024: 3.8xQ1 2025: 5.1xQ2 2025: 5.7xQ3 2025: 6.8x
QuarterNet LeverageStatus
Q3 20256.8xHigh
Q2 20255.7xHigh
Q1 20255.1xHigh
Q4 20243.8xElevated
Q3 20243.4xElevated
Q2 202412.7xHigh
Q1 202414.2xHigh
Q4 202311.9xHigh

ACHC's net debt is about 6.8 years of its operating earnings (EBITDA), up from 3.4 years a year ago.

ACHC Weekly Momentum

MetricValueStatus
RSI70.3Overbought
Stochastic70.2Neutral

ACHC's weekly RSI is 70 (overbought) and its Stochastic is 70 (neutral).

ACHC PE vs Healthcare Sector

MetricACHCSector medianRelative
PEN/A26x—

ACHC has no meaningful PE right now: it lost money over the past year.

ACHC Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$31.520% above
20 week MA$30.923% above
50 week MA$24.852% above
100 week MA$25.946% above
200 week MA$48.622% below

ACHC has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 22% below its 200-week average.

ACHC Yearly ROI

YearStart priceEnd priceROI
2020$33.0$49.3+49%
2021$49.3$59.1+20%
2022$59.1$83.0+40%
2023$83.0$77.8-6.3%
2024$77.8$38.0-51%
2025$38.0$14.7-61%
2026 YTD$14.7$37.8+157%

ACHC has finished three years in a row lower, and it's up 157% so far in 2026.

Give your agent the market.

Get API key